Prinston Pharmaceutical Inc.
Jack Guan has extensive work experience in the pharmaceutical industry. Jack is currently serving as the Vice President at Prinston Laboratories since 2022. Prior to that, they held various leadership positions at Prinston Pharmaceutical Inc., including Executive Director, Head of Analytical R&D, and Senior Director, Analytical Operations from 2018 to 2022. Before joining Prinston Pharmaceutical Inc., Jack worked at Jiuzhou Pharma as the Quality Head of R&D, Analytical R&D, and Compliance from 2012 to 2018. Jack also worked at Sandoz, a Novartis company, as a Sr. Scientist from 2009 to 2012, and at Teva Pharmaceuticals as a Senior Chemist from 2006 to 2009. In addition, Jack has experience working at Phytoceutica, Inc. as the Chemistry Lead from 2004 to 2006, and at Albert Einstein College of Medicine as an Instructor of Biophysics from 2000 to 2004.
Jack Guan has a Ph.D. in Organic Chemistry from the Technical Institute of Physics & Chemistry, the Chinese Academy of Sciences. Jack also holds a degree as a Humboldt Fellow in Biochemistry from Ludwig-Maximilians-Universität München. Additionally, Jack has certifications in Project Management Professional (PMP) from the Project Management Institute and Regulatory Affairs Professional from the Regulatory Affairs Professionals Society (RAPS).
This person is not in any teams
This person is not in any offices
Prinston Pharmaceutical Inc.
We are a fully integrated pharmaceutical company located in Cranbury, engaged in developing and sales & marketing of generic pharmaceutical products in North American and South American markets. Since launching our first product, Benazepril in 2010, we have launched 11 products in U.S. market. Through reliable products’ quality, manufacturing capability and competitively strategic API resources from China, we have successfully reduced the medical cost for American buyers and help millions of patients against their illness.